Digital Heroes Marks 2,000 Brand Launches Across 55 Countries Through Global Technology Services 
ANT Law Firm Strengthens Its Orlando Legal Services for Car Accident, Slip and Fall, and Wrongful Death Victims 
LumenIsle Launches Australian Market Service Review and International Video Traceability Initiative for Memorial Diamonds 
HiBob Named Best HR Management Software in the UK for 2026 
Ionik Announces 30-Day Extension of Senior Debt Facility Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids
In the Phase 3 LIBERTY 1 and LIBERTY 2 studies, MYFEMBREE demonstrated 72.1% and 71.2%…
BeyondSpring to Present at the Jefferies Virtual Healthcare Conference on June 3, 2021
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (“BeyondSpring”) (NASDAQ: BYSI), a global…
Zealand Pharma to participate in Jefferies Virtual Healthcare Conference
Company announcement – No. 32/ 2021 Zealand Pharma to participate in Jefferies Virtual Healthcare Conference Copenhagen,…
Zosano Pharma Announces Publication of Clinical Data Regarding the Long-term use of Qtrypta™ for the Treatment of Acute Migraine in The Journal of Headache and Pain
FREMONT, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company,…
Timber Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2b CONTROL Study Evaluating TMB-001 in Congenital Ichthyosis
– Company plans to ask for end-of-Phase 2 meeting with FDA by end of 2021…
Celldex to Present at the Jefferies 2021 Virtual Healthcare Conference
HAMPTON, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Notice of Saniona AB extraordinary shareholders’ meeting
PRESS RELEASE May 26, 2021 The English text is an unofficial translation. In case of…
AB Science communicates results from Phase 3 study evaluating masitinib in prostate cancer
PRESS RELEASE AB SCIENCE COMMUNICATES RESULTS FROM PHASE 3 STUDY EVALUATING MASITINIB IN PROSTATE CANCER…
Bulletin from the Saniona AB annual shareholders’ meeting on May 26, 2021, and information regarding planned extraordinary shareholders’ meeting
PRESS RELEASE May 26, 2021 Today, on May 26, 2021, the annual shareholders’ meeting was…
CancerVAX Announces Research Program to Develop Its First Immunotherapy Cancer Treatment
The Company has entered into an agreement with UCLA to develop an immunotherapy breakthrough targeted…
Olainfarm invites to First Quarter 2021 Investor Conference Webinar
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor…
Novome Biotechnologies Appoints Dr. David N. Cook and Zachary Hornby to its Board of Directors
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Novome Biotechnologies, Inc., a biotechnology…
AIM ImmunoTech Announces Positive Safety Data from the Third Cohort of Its Phase 1 Intranasal Clinical Trial
OCALA, Fla., May 26, 2021 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) today…
Rafael Pharmaceuticals to Present New Pancreatic Cancer and Biliary Tract Cancer Data featuring CPI-613® (Devimistat) at the American Society of Clinical Oncology (ASCO) 2021 Virtual Scientific Program
CRANBURY, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”),…
Kymera Therapeutics Presents New Data Demonstrating Proof-of-Degradation Using Novel Tissue-Restricted E3 Ligase
Novel E3 ligase identified by Kymera’s Whole-Body Atlas is expressed in selected tissues while broadly…
AXIM® Biotechnologies Completes Pre-Clinical Drug Studies on SPX-1009 Compound Proving Suppression of Melanoma Cells
SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM”…
Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
EWING, N.J., May 26, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…
Albireo to Present at Upcoming Jefferies and William Blair Virtual Investor Conferences
BOSTON, May 26, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver…
Bellerophon Appoints Naseem Amin, M.D. as Chairman of its Board of Directors
Dr. Amin Has Served as an Independent Director Since 2015 and Succeeds Jonathan Peacock Following…
Evaxion Biotech Appoints Lars Holtug to the Board of Directors
COPENHAGEN, Denmark, May 26, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage…